Does GEMCITABINE Cause Malignant neoplasm progression? 1,962 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,962 reports of Malignant neoplasm progression have been filed in association with GEMCITABINE (Gemcitabine). This represents 6.3% of all adverse event reports for GEMCITABINE.
1,962
Reports of Malignant neoplasm progression with GEMCITABINE
6.3%
of all GEMCITABINE reports
602
Deaths
411
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GEMCITABINE?
Of the 1,962 reports, 602 (30.7%) resulted in death, 411 (20.9%) required hospitalization, and 86 (4.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 1,962 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
Fatigue (1,098)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which GEMCITABINE Alternatives Have Lower Malignant neoplasm progression Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN